dependence of SNA-Beta-2-glycoprotein 1 binding using TMT analysis. Each channel was quantified as a ratio compared to the blank reference channel 126. 6 The two forms of fetuin-B/Beta-2-glycoprotein 1 (i.e. untreated (-), and α2, 3, 6, 8- neuraminidase (sialidase) treated (+)) were incubated with SNA/blank resin. Bound proteins were eluted and digested and the trypsinized peptides were labelled with 10plex TMT reagents and subsequently analyzed via LC-MS/MS. TMT analysis largely followed expectations (Fig.   1b, c) , with a drop in binding by both proteins following sialidase treatment, suggesting that alterations in protein-protein interactions due to sialic acid changes can be efficiently analyzed using the immobilized bait protein-soluble prey method. The method provides a degree of flexibility. First, the impact of bait protein glycosylation, provided the bait is a glycoprotein, can also be manipulated. Second, the changes of glycosylation on both bait and prey proteins can be achieved by glycosidases or glycotransferases.
Determine the impact of N-glycosylation on platelet-collagen PPIs
The fine details dictating platelet receptor protein binding to collagen are critical to understanding the nature of the adhesive receptor/protein-collagen interaction, as well as the factors necessary for optimal binding. The use of quantitative proteomics provides a nonhypothesis driven characterization of PPIs between platelet proteins and collagen with altered glycosylation states. The identification of alterations in platelet protein-collagen binding following enzymatic deglycosylation will facilitate the discovery of novel, glycan-regulated protein-protein interactions with potential, downstream therapeutic applications. We applied the FOGIPPI method to platelet protein binding to collagen. Immobilized collagen resin was generated using AminoLink agarose resin. Human platelet proteins were isolated from plateletrich plasma (PRP) and lysed in a lysis buffer containing a non-ionic detergent (Triton X-100) to ensure the solubilization of the majority of membrane-bound adhesive receptors without 7 denaturing the protein structure or protein complexes, maintaining the capacity for proteinprotein interaction (PPI). Lysed platelet proteins were treated with either PBS, PNGase F, or sialidase, and each of the treated platelet proteins were incubated with agarose-bound collagen ( Supplementary Fig. 1 ).
Proteins were thoroughly washed and eluted under acidic conditions. Proteins released from different washing conditions were monitored by mass spectrometry analyses (Supplementary Supplementary Fig. 4 ). The TMT labelled peptides were pooled, fractionated using basic reverse phase liquid chromatography (bRPLC). The bRPLC fractions were concatenated ( Supplementary Fig. 5 ) into 24 fractions and LC-MS/MS analysis was used to identify and quantify changes in collagen binding following glycan manipulation. MS/MS analysis was operated in a data-independent manner, necessitating the use of technical replicates for each channel ( Supplementary Fig. 4 ). Following TMT LC-MS/MS analysis of collagen-bound platelet proteins, 2,255 proteins were identified. This high protein identification number is typical of affinity enrichment followed by 2D-LC-MS/MS analysis, as proteins that bind non-specifically to the resin or indirectly to collagen through protein complex formed by collagen binding proteins are included in the analysis, indeed for many proteins, the TMT intensity values were detected in the control with the blank beads. 26 Reproducibility analyses revealed close agreement between channels ( Supplementary Fig. 6 ). Proteins that interacted with collagen were stratified based on both their statistical significance and binding strength, with a minimum inclusion criteria of 2.0-fold change and P value of less than 0.05 in platelet protein and collagen interactions. Volcano plots were generated in order to visualize the alterations in protein binding following glycan manipulation (Fig. 2) , yielding distinct profiles. (Fig. 2) . Removal of N-glycans or sialic acid from platelet glycoproteins, in general, appears to largely decrease platelet protein binding to collagen (Fig. 2a, 2b) , indicating an overall inhibitory role for N-linked glycans or sialic acids of platelet glycoproteins in platelet protein-collagen interactions. Conversely, collagen deglycosylation generally appears to result in higher protein binding (Fig. 2c, d ), indicating that the glycans on collagen may play some negative role in platelet protein-collagen interactions that limits binding.
Intact glycopeptide analysis identifies the specific glycoproteins and their glycan changes associated with the alterations in PPI
In order to rationalize the N-glycan dependency of binding interaction between platelet adhesive receptors/proteins and collagen, we analyzed the platelet sample using intact glycopeptide analysis. Intact glycopeptide analysis allowed us to site-specifically analyze individual glycans from a complex mixture of proteins. In order to estimate the contribution of intact glycopeptides from platelet versus contaminating plasma, samples were prepared from either washed platelets or platelet-free plasma. Abundant serum proteins were removed using a multiple affinity removal system-6 (MARS-6) (Fig. 3a) . The intact glycopeptide data was searched using the software package GPQuest 3.0. 27 In total, 3111 unique glycopeptides were identified with a 1% FDR for the platelet sample, corresponding to 192 distinct N-glycans from 278 glycoproteins. For the plasma sample, 3452 unique glycopeptides were identified (1% FDR), including 216 distinct N-glycans, corresponding to 181 glycoproteins. Analysis of the overlapping glycopeptides shared between platelet and plasma, indicated a moderate number of glycopeptides (819) in common between the two samples (Fig. 3b) . The majority of glycopeptides identified between the two samples were unshared, however, there was significant 11 overlap at the glycoprotein level, with 40% of the glycoproteins shared between platelet and plasma, with only 15% of the glycoproteins identified unique to plasma (Fig. 3c) . The disparity between the identifications at the glycopeptide versus glycoprotein levels, suggests that the patterns of glycosylation between platelet and plasma samples is different. While the peptide portion of a given protein may be shared, the glycan portion appears to be largely unique and source specific. The unique N-glycans identified from platelet and plasma intact glycopeptide samples were divided into the three major categories (i.e. high-mannose, hybrid-type, and Table 1 ).
Collagen-enriched proteins in the TMT data set shared 10% unique glycoproteins with the platelet-derived sample, with only a 2.8% overlap with unique plasma-derived glycoproteins ( Supplementary Fig. 7 ). The results suggest that the majority of the glycoproteins binding to collagen were from platelets, rather than contaminating plasma glycoproteins. Based on intact glycopeptide analysis, the majority of platelet-derived glycopeptides identified lacked significant sialylation in comparison to plasma proteins. The observation is not unexpected as platelets are known to be enriched with sialidase enzymes that are secreted and remodel the glycosylation patterns of the platelet glycoproteins, with desialylation accelerating platelet clearance. 13 10
Major platelet adhesive receptors and proteins require N-glycans for collagen binding
We stratified the identified proteins that were significantly impacted by de-glycosylation proteins that bind to other constituents of the ECM beyond collagen, including podoplanin, thrombospondin, and laminin.
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Among the identified adhesive receptors/proteins that bind directly to collagen, both of the major collagen binding receptors, GPVI and (ITGA2/ITGB1), were identified and both GPVI and ITGA2 demonstrated a > 2-fold loss of binding following PNGase F treatment of the platelet lysate, while ITGB1 was more moderately impacted (Fig. 5h) . Neither receptor was significantly impacted by either sialidase treatment or collagen glycosylation. The findings for GPVI were in agreement with a prior publication which found that PNGase F-treated recombinant, GPVI, had a lower affinity for collagen. 28 Von Willebrand Factor (VWF), a central collagen binding protein, and the first adhesive protein to initiate platelet tethering to collagen 29 was found to be critically dependent upon both N-glycosylation and sialylation (Fig. 5a , e) but largely unaffected by collagen glycosylation. Previous reports have shown that N-glycosylation negatively impacts platelet adhesion to VWF in the absence of collagen, 30 however, our data indicates a positive role for N-glycans in VWF adhesion to collagen, at least under non-shear conditions. Consistent with previous studies, 31 32 we found FN1-collagen binding was positively influenced by Nglycosylation, and binding by FN1 to collagen dropped more than 2-fold following PNGase F treatment. In agreement with previous studies, 33 34 we found the PPI between vitronectin (VTN) and collagen to be enhanced 2.2-fold following sialidase treatment (Fig. 5a ).
Many of the identified platelet adhesion receptors bind indirectly to collagen through ECM binding proteins, including VWF, FN1, and VTN. One of the most important platelet receptors is the GPIbα, GPIbβ, GPV, and GPIX (GPIb-V-IX) receptor complex that forms the incipient platelet tether to VWF bound to the nascently exposed collagen. GPIb-V-IX binds to the highaffinity surface created when VWF unrolls from a globular to a filamental conformation on the exposed collagen surface at the site of vascular injury. 35 36 Each individual component of the GPIb-V-IX receptor complex demonstrated a concomitant loss (i.e. > 2-fold) of binding presumably following the loss VWF binding to collagen, and, with the exception of GPIbα/β, was similarly unaffected by collagen glycosylation (Fig. 5h) . Similarly, FN1 plays a central role in platelet adhesion, and acts as the substrate for integrins ITGA2b/ITGB3, ITGAV/ITGB3, ITGA4/ITGB1, and ITGA5/ITGB1. 37 With the exception of ITGAV and ITGB1, the remaining FN1 adhering integrins identified exhibited a ≥ 2-fold loss in binding following PNGase F treatment of the platelet lysate (Fig. 5h) . The FN1/VTN binding receptor integrin αvβ3 was differentially impacted by platelet glycan manipulation, with ITGAV exhibiting little change in binding, while ITGB3 binding was found to be highly dependent upon N-glycosylation, demonstrating a 3-fold drop in binding following PNGase F treatment of the platelet lysate. The finding was in agreement with previous literature.
38 39 40 A number of ECM-binding platelet adhesive receptors were identified that targeted constituents of the ECM other than collagen. In the present study, glycoprotein IV (CD36), a multifunctional receptor known to bind to thrombospondin, was identified and found to be Nglycan dependent, demonstrating a sensitivity to PNGase F treatment of the platelet lysate and collagen (Fig. 5b) . In addition, several receptors bind to alternative ECM proteins, such as laminins which are concomitantly exposed with collagen during vascular injury. ITGA6/ITGB1, which is a known laminin-binding receptor, was shown to lose affinity following deglycosylation of N-glycans from the platelet proteins (Fig. 5h) . The glycan binding protein Ctype lectin-like receptor-2 (CLEC-2), which serves a critical role in platelet activation, 41 was also found to have lower affinity for the collagen resin following PNGase F treatment of the platelet lysate. The natural agonist for CLEC-2, podoplanin was not identified in this study, however, CLEC-2 exhibited a 2.5-fold decrease in binding following de-N-glycosylation. For the 18 majority of platelet adhesive receptors/proteins that demonstrated a large binding change, the pvalues were calculated and found to be statistically significant (Fig. 5i) . 
Roles of glycans on platelet protein-collagen binding
Following the observation that the binding of many adhesive receptors and proteins to collagen was highly dependent on N-glycosylation, we analyzed the N-glycopeptides from the platelet adhesion receptors and collagen binding proteins that demonstrated a ≥ 2-fold change (positive or negative) in collagen binding following PNGase F treatment. Using data generated from our intact glycopeptide library (Fig. 3) , we identified glycopeptides from five collagen 19 binding proteins and nine platelet receptor proteins that exhibited reduced/enhanced collagen binding following PNGase F/sialidase treatment of platelet lysate ( Table 1) . Many of the glycopeptides that were identified corresponded to major collagen-binding receptors and proteins. While glycosylation of the soluble adhesive proteins exhibited the expected abundance of complex and hybrid-type N-glycans (Table 1a) , many of the adhesive receptors (i.e. integrins and platelet glycoproteins) were found to contain an abundance of oligomannose glycans (Table   1b ). The observation was surprising, considering the low degree of oligomannose glycans commonly identified on mammalian plasma proteins. 42 However, a number of megakaryocyte receptors, including ITGB3 have been shown to bear underprocessed N-glycans even after receptor maturation. 43 44 The abundance of oligomannose glycans on platelet receptor proteins suggests a structural rather than an electrostatic function for N-glycosylation of platelet receptor proteins, as no significant binding change was observed following sialidase treatment (with the exception of ITGA4). Indeed, an indirect structural role for N-glycosylation, rather than a direct glycan function has been recently suggested for ITGA2b/ITGB3 and ITGAV/ITGB3 ligand binding. 40 As a counter example, the ECM binding protein, histidine-rich glycoprotein (HRG), demonstrated increased binding to collagen following either PNGase F or sialidase treatment (i.e.
~5.0 and ~4.0-fold, respectively). The binding behavior of HRG could be rationalized based on HRG's substrate binding mode. HRG is known to bind to a number of negatively charged substrates via a cationic histidine-rich region. 45 Using intact glycopeptide analysis of the platelet lysate, we identified 26 unique intact glycopeptides from HRG, all of which contained highly processed hybrid and complex-type glycans, containing 23% sialylation. 
Discussion
A number of landmark studies using AP-MS have established methods to study the impact of PTMs on PPIs. 46 Platelet adhesion to collagen is a multistep process requiring the sequential interaction of multiple adhesive receptors (GPIb-IX-V, GPVI, and Integrin α2/β1) with the extracellular matrix components collagen/VWF to facilitate secure tethering of the platelet to the disrupted vascular endothelium. 29 Adhesive proteins participate in dual roles in the coagulation process by both activating platelet receptors, as well as bolstering the adhesions by acting as "cement." Many of 21 the major adhesive proteins are also known glycoproteins. 29 The application of affinity purification coupled to mass spectrometry (AP-MS) to elucidate the function of glycosylation in protein-protein interactions (FOGIPPI) provides a unique and powerful method that can potentially identify glycans that regulate coagulation-related proteins. Expanding our understanding of the role of glycosylation in platelet-collagen interactions has the potential to uncover novel therapeutic pathways.
The approach was validated using an SNA-fetuin-B proof-of-concept system demonstrating the feasibility of the immobilized "bait"-soluble "prey" concept to study the function of glycans in PPIs. Application of the method to a complex system composed of immobilized collagen and platelet lysate revealed a striking glycan dependence among primary collagen-binding proteins.
Using the immobilized "bait', soluble "prey" method, we generated the first extensive glycandependent interaction analysis, identifying all major primary platelet adhesive receptors/proteins and revealing that the majority, including GP6, GPIb-V-IX, and integrin α2β1, are strongly reliant upon N-glycosylation for proper binding interactions. It is likely that N-glycosylation could impact substrate binding either by direct facilitating or interfering protein-protein interactions, or by modulating the optimal orientation of the glycoproteins to facilitate PPIs. The use of intact glycopeptide analysis of the platelet lysate assisted in rationalizing the structural role of N-glycosylation in the PPIs, although direct assignment of glycan function cannot be determined from this method. Intact glycopeptide analysis revealed the preponderance of oligomannose glycans, particularly among integrins, suggesting a structural rather than electrostatic role for glycans, as would be expected from more highly processed, sialylated glycans (Supplementary Table 2 ).
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Despite the advantages and utility afforded by the immobilized "bait"/soluble "prey" method for determining the role of N-glycosylation in PPIs, there are a number of limitations that should be considered. First, endemic to all AP-MS experiments is the presence of non-specific binding proteins in addition to the proteins of interest. In our analysis, a number of nonglycosylated cytoskeletal proteins were impacted by N-glycan manipulation, however the change in affinity was likely an artifact of the alteration of charge/hydrophobicity following deglycosylation/desialylation. The changes of these protein binding to collagen could also be the result of their binding to the primary proteins whose binding to collagen is regulated by glycosylation. The issue of co-purifying non-specific binding proteins could potentially be addressed by incorporating unspecific binders as crucial elements in the bioinformatics pathway to determine the background binding as described in this study using conjugated resin as control, the method was described in other AP-MS studies such as the recent study in a LFQ/SILAC AP-MS yeast protein study. 26 Similarly, glycoproteins that bound more strongly to the bait following deglycosylation may have bound non-specifically via hydrophobic/van der Waals forces, rather than an increased specific binding affinity; accurately determining true interactions versus non- was achieved using ultrasonication in 15 s pulses (6x) at 70% maximum power. The lysed platelets were cooled on ice for one min between sonication cycles. Platelet lysate was separated from cellular debris by centrifugation at 1500 g. The protein concentration of the platelet lysate was estimated using bicinchoninic acid (BCA) assay (Thermo Scientific).
Collagen affinity column preparation
Protein-derivitized agarose was generated using a modified version of a method reported previously by our group. 53 Briefly, 500 µL of AminoLink ® Plus coupling resin (1 mL of a 50% slurry) was incubated with 5-fold diluted collagen (100 µg protein in 500 µL buffer (40 mM sodium citrate and 20 mM sodium carbonate, pH 10) at 37ºC for 4 hrs on a rotisserie shaker. 500 mM sodium cyanoborohydride in 1X PBS was added (final concentration, 45.5 mM), and the sample was incubated at 37ºC for 2 hrs with mixing. The resin was washed twice with 1X PBS, and incubated with 50 mM sodium cyanoborohydride and the sample was incubated again for 2 hrs at 37ºC with mixing. The unreacted aldehyde sites remaining on the beads were blocked via incubation with 1 M Tris-HCl (pH 7.6) in the presence of 50 mM sodium cyanoborohydride. The sample was incubated at 37ºC for 1 hr with mixing. The resin was washed 3X using 1M NaCl, and 10X with 1X PBS. The columns were stored in 1X PBS containing 0.02% NaN3 at 4ºC before use. Coupling efficiency was determined by BCA assay comparing the flow-through to starting solution. For both collagen I and collagen IV, coupling was > 99% with nearly 100 µg collagen loaded in each column.
Platelet protein collagen-affinity enrichment
Platelet lysate (1 mg) in PBS containing 50 mM MnCl2 was incubated in each collagenaffinity column for 4 hrs at 37ºC on a rotisserie shaker. Unbound proteins were removed by sequential washes (10X using 1X PBS). Bound proteins were eluted with 1% TFA. The eluent was neutralized with 2 M ammonium bicarbonate and dried via speedvac. Proteins in the eluent were denatured at 37ºC using 8 M urea in 1 M ammonium bicarbonate and the disulfide bonds were reduced with 5 mM dithiothreitol (DTT). Reduced cysteine residues were alkylated at 37ºC
by the addition of 10 mM iodoacetamide in the dark. The denatured, alkylated proteins were 26 digested by the addition of Lys-C/trypsin mix (Promega) each in a 1/50 enzyme/protein w/w ratio. The sample was incubated at 37ºC for 1 hr, and the solution was diluted two-fold with 50 mM ammonium bicarbonate to reduce the concentration of urea to 4 M. Trypsin was added in a 1/30 enzyme/protein w/w ratio, and the solution incubated for an additional 1 hr. The solution was diluted four-fold to a final urea concentration of 2 M, and an additional aliquot of trypsin was added, and the solution was incubated at 37ºC overnight. Following digestion, the sample was dried and dissolved in 1% TFA. The pH of the solution was acidified to pH < 2 with 10%
TFA, and the tryptic digest was desalted using C18 stage tips (3M Empore, Minneapolis, MN, USA). Residual detergent was removed from label-free samples using strong-cation exchange (SCX) tips (Glygen Corp., Columbia, MD). Peptides were labelled with 10-plex TMT reagents (Thermo Scientific) as described elsewhere. 54, 55 TMT reagents were prepared by the addition of 40 µL dry acetonitrile to each channel (final concentration 20 µg/µL). Dried peptides (5 µg) were dissolved in 200 mM HEPES, pH 8.5, and 5 µL of the appropriate TMT reagent was added to each sample. TMT channels 126 and 127N were reserved for 'blank' channels representing the background noise arising from non-specific protein interactions with the blocked agarose beads. The remaining reagents were used to label samples in the order described in figure X.
Labelling was performed at RT for 2 hrs and the reaction was quenched by the addition of 5% hydroxylamine and shaking for 30 min. Labelled samples were acidified by the addition of 1%
TFA and pooled. The pooled samples were further acidified to pH > 2 by the addition of 10%
TFA, and the pooled samples were desalted using C18 stage tips. Residual detergent was removed using SCX purification.
Liquid-chromatography electrospray ionization tandem mass spectrometry 27 LC-MS experiments were performed using either a Q-Exactive mass spectrometer (Thermo Fisher Scientific) equipped with a Dionex Ultimate 3000 RSLC nano system with a 75 µm × 15 cm Acclaim PepMap100 separating column protected with a 2-cm guard column (Thermo were enabled. A dynamic exclusion window of 15 s was used to discriminate between previously selected ions.
Database search
All TMT-labelled LC-MS/MS data were searched using Proteome Discoverer 2.2 (Thermo Scientific) searched against UniProtKB/Swiss-Prot human protein databases.
Data processing software
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Intact glycopeptide analysis was performed using GPQuest 3.0. 27 All Venn diagrams were generated using eulerAPE software. 56 Heat maps were generated using Gitools 2.3.1 software suite.
Intact glycopeptide analysis
Raw MS files were converted to mzML format using MSConvert from Proteowizard and searched against peptide and glycan database using GPQuest. 27 Oxonium ion containing spectra were extracted using HexNAc (204. 
